| Name | Cavrotolimod |
|---|
| Description | Cavrotolimod is an immunostimulatory spherical nucleic acid (SNA) modified with type B CpG oligonucleotides designed to agonize TLR9 and elicit immune responses useful in oncology applications. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C300H423N71O161P26S23 |
|---|---|
| Molecular Weight | 9142.88 |